Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Editorial introductions

Editorial introductions Downloaded from http://journals.lww.com/co-hivandaids by BhDMf5ePHKbH4TTImqenVJ2toCr/9wZZjwPUWvYES9l2nY+zyylnl33NGMK6MRsx on 10/23/2020 URRENT Editorial introduction PINION Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into nine sections that are reviewed once a year. Each section is assigned one or two Section Editors, leading authorities in the area, who identify the most important topics at that time. Here we are pleased to introduce the Section Editor for this issue. SECTION EDITOR University and obtained his Ph.D. degree from New York University School of Medicine in the USA. Zhiwei Chen From 1996 to 2007, he was trained with Prof. David D. Ho and progressed from a post-doc to a research Professor Zhiwei Chen, PhD scientist, and then to a staff investigator/assistant Director, AIDS Institute Professor, professor all at ADARC. In 2007, he joined The Department of Microbiology, LKS University of Hong Kong as an associate professor Faculty of Medicine, The Univer- in Microbiology. sity of Hong Kong Since 1991, he has been engaged in studies of Prof. Zhiwei Chen is the HIV origin, molecular mechanisms of HIV/SIV founding director of the AIDS entry, and AIDS vaccine. After the SARS outbreak Institute, which was established in 2003, he has studied SARS-CoV vaccine and at The University of Hong Kong mechanism underlying vaccine-enhanced acute Li Ka Shing Faculty of Medicine in lung injury. Recently, he is studying COVID-19 2007. He is now a tenured full vaccine and immunopathogenesis underlying the professor in Microbiology with great interests in acute SARS-CoV-2 infection. He has published over a HIV and SARS vaccine and immunotherapeutic hundred thirty peer-reviewed SCI papers. He serves cure research. currently as the chairman of Hong Kong Society for In 1996, he finished his postgraduate studies Immunology and an editorial board member for with Prof. Preston A. Marx at the Aaron Diamond AIDS, JAIDS, JMP and JNIP. (http://www.med.hku.hk/aidsinst) AIDS Research Center (ADARC) of the Rockefeller 1746-630X Copyright  2020 Wolters Kluwer Health, Inc. All rights reserved. www.co-hivandaids.com Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved. Downloaded from http://journals.lww.com/co-hivandaids by BhDMf5ePHKbH4TTImqenVJ2toCr/9wZZjwPUWvYES9l2nY+zyylnl33NGMK6MRsx on 10/23/2020 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in HIV & AIDS Wolters Kluwer Health

Editorial introductions

,
Current Opinion in HIV & AIDS , Volume 15 (6) – Nov 1, 2020

Loading next page...
 
/lp/wolters-kluwer-health/editorial-introductions-c4AqmIP0Rc

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
1746-630X
eISSN
1746-6318
DOI
10.1097/COH.0000000000000647
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/co-hivandaids by BhDMf5ePHKbH4TTImqenVJ2toCr/9wZZjwPUWvYES9l2nY+zyylnl33NGMK6MRsx on 10/23/2020 URRENT Editorial introduction PINION Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into nine sections that are reviewed once a year. Each section is assigned one or two Section Editors, leading authorities in the area, who identify the most important topics at that time. Here we are pleased to introduce the Section Editor for this issue. SECTION EDITOR University and obtained his Ph.D. degree from New York University School of Medicine in the USA. Zhiwei Chen From 1996 to 2007, he was trained with Prof. David D. Ho and progressed from a post-doc to a research Professor Zhiwei Chen, PhD scientist, and then to a staff investigator/assistant Director, AIDS Institute Professor, professor all at ADARC. In 2007, he joined The Department of Microbiology, LKS University of Hong Kong as an associate professor Faculty of Medicine, The Univer- in Microbiology. sity of Hong Kong Since 1991, he has been engaged in studies of Prof. Zhiwei Chen is the HIV origin, molecular mechanisms of HIV/SIV founding director of the AIDS entry, and AIDS vaccine. After the SARS outbreak Institute, which was established in 2003, he has studied SARS-CoV vaccine and at The University of Hong Kong mechanism underlying vaccine-enhanced acute Li Ka Shing Faculty of Medicine in lung injury. Recently, he is studying COVID-19 2007. He is now a tenured full vaccine and immunopathogenesis underlying the professor in Microbiology with great interests in acute SARS-CoV-2 infection. He has published over a HIV and SARS vaccine and immunotherapeutic hundred thirty peer-reviewed SCI papers. He serves cure research. currently as the chairman of Hong Kong Society for In 1996, he finished his postgraduate studies Immunology and an editorial board member for with Prof. Preston A. Marx at the Aaron Diamond AIDS, JAIDS, JMP and JNIP. (http://www.med.hku.hk/aidsinst) AIDS Research Center (ADARC) of the Rockefeller 1746-630X Copyright  2020 Wolters Kluwer Health, Inc. All rights reserved. www.co-hivandaids.com Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved. Downloaded from http://journals.lww.com/co-hivandaids by BhDMf5ePHKbH4TTImqenVJ2toCr/9wZZjwPUWvYES9l2nY+zyylnl33NGMK6MRsx on 10/23/2020

Journal

Current Opinion in HIV & AIDSWolters Kluwer Health

Published: Nov 1, 2020

There are no references for this article.